Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling

Upstream and downstream of mTOR

Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083

Defining the role of mTOR in cancer

Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling

Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797

The Tuberous Sclerosis Complex

Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793

Growing roles for the mTOR pathway

Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,590

Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway

Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

Lapointe, J., Li, C., Higgins, J., van de Rijn, M., Bair, E., Montgomery, K. D., Ferrari, M. K., Egevad, L., Rayford, W., Bergerheim, U. S. R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304146101 · Cited by 1,282

mTOR Signaling in Growth Control and Disease

Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509

Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy

Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D. A., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,154

mTOR: from growth signal integration to cancer, diabetes and ageing

Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941

Autophagy: cellular and molecular mechanisms

Glick, D. R., Barth, S., & Macleod, K. F. (2010) · The Journal of Pathology · doi:10.1002/path.2697 · Cited by 3,995

mTOR at the nexus of nutrition, growth, ageing and disease

Liu, G. Y., & Sabatini, D. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0199-y · Cited by 2,737

Molecular mechanisms of mTOR-mediated translational control

Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445

PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase

D’Hulst, G., Soro-Arnaiz, I., Masschelein, E., Veys, K., Fitzgerald, G., Smeuninx, B., Kim, S., Deldicque, L., Blaauw, B., Carmeliet, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13889-6 · Cited by 2,310

mTOR signaling at a glance

Laplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,284

MTOR: a pharmacologic target for autophagy regulation

Kim, Y. C., & Guan, K.-L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73939 · Cited by 2,126

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693

Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages

Ip, W., Hoshi, N., Shouval, D. S., Snapper, S. B., & Medzhitov, R. M. (2017) · Science · doi:10.1126/science.aal3535 · Cited by 1,382

Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress

Sengupta, S., Peterson, T. R., & Sabatini, D. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.026 · Cited by 1,275

The TSC1–TSC2 complex: a molecular switchboard controlling cell growth

Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

Magnuson, B., Ekim, B., & Fingar, D. C. (2012) · Biochemical Journal · doi:10.1042/bj20110892 · Cited by 1,015

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner

Kalender, A., Selvaraj, A., Kim, S. Y., Gulati, P., Brûlé, S., Viollet, B., Kemp, B. E., Bardeesy, N., Dennis, P., Schlager, J. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.014 · Cited by 889

Hypoxia signalling through mTOR and the unfolded protein response in cancer

Wouters, B. G., & Koritzinsky, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2501 · Cited by 894

Regulation and metabolic functions of mTORC1 and mTORC2

Szwed, A., Kim, E., & Jacinto, E. (2021) · Physiological Reviews · doi:10.1152/physrev.00026.2020 · Cited by 855

Autophagy as a target for anticancer therapy

Jankú, F., McConkey, D. J., Hong, D. S., & Kurzrock, R. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.71 · Cited by 814

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

Yu, L., Wei, J., & Liu, P. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.019 · Cited by 818

Hypoxia and Metabolic Adaptation of Cancer Cells

Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724

A complex interplay between Akt, TSC2 and the two mTOR complexes

Huang, J., & Manning, B. D. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370217 · Cited by 724

Signal integration by mTORC1 coordinates nutrient input with biosynthetic output

Dibble, C. C., & Manning, B. D. (2013) · Nature Cell Biology · doi:10.1038/ncb2763 · Cited by 743

Autophagy regulation by nutrient signaling

Russell, R. C., Yuan, H., & Guan, K. (2013) · Cell Research · doi:10.1038/cr.2013.166 · Cited by 740

miR-221 overexpression contributes to liver tumorigenesis

Pineau, P., Volinia, S., McJunkin, K., Marchio, A., Battiston, C., Terris, B., Mazzaferro, V., Lowe, S. W., Croce, C. M., & Dejean, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907904107 · Cited by 698

Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1

Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J.-F., Giorgetti-Peraldi, S., & Bost, F. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1769 · Cited by 616

The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development

Morrison, D. K. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.10.003 · Cited by 609

mTOR coordinates protein synthesis, mitochondrial activity and proliferation

Morita, M., Gravel, S.-P., Hulea, L., Larsson, O., Pollak, M., St-Pierre, J., & Topisirovic, I. (2015) · Cell Cycle · doi:10.4161/15384101.2014.991572 · Cited by 552

mTOR as a key regulator in maintaining skeletal muscle mass

Yoon, M.-S. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00788 · Cited by 495

Energetics, epigenetics, mitochondrial genetics

Wallace, D. C., & Fan, W. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.09.006 · Cited by 519

Crosstalk between Glucocorticoid Receptor and Nutritional Sensor mTOR in Skeletal Muscle

Shimizu, N., Yoshikawa, N., Ito, N., Maruyama, T., Suzuki, Y., Takeda, S.-I., Nakae, J., Tagata, Y., Nishitani, S., Takehana, K., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.001 · Cited by 498

Regulation of TFEB and V‐ATPases by mTORC1

Peña‐Llopis, S., Vega-Rubín-de-Celis, S., Schwartz, J. C., Wolff, N. C., Tran, T. A. T., Zou, L., Xie, X., Corey, D. R., & Brugarolas, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.257 · Cited by 472

Rapamycin Protects against Neuron Death inIn VitroandIn VivoModels of Parkinson's Disease

Malagelada, C., Jin, Z. H., Jackson-Lewis, V. R., Przedborski, S., & Greene, L. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3944-09.2010 · Cited by 465

Rapamycin and mTOR kinase inhibitors

Ballou, L. M., & Lin, R. Z. (2008) · Journal of Chemical Biology · doi:10.1007/s12154-008-0003-5 · Cited by 458

mTOR , metabolism, and the regulation of T‐cell differentiation and function

Waickman, A. T., & Powell, J. D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01152.x · Cited by 420

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy

Wander, S. A., Hennessy, B. T., & Slingerland, J. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44145 · Cited by 427

Akt-dependent and -independent mechanisms of mTOR regulation in cancer

Memmott, R. M., & Dennis, P. A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.004 · Cited by 392

Amino acid regulation of TOR complex 1

Avruch, J., Long, X., Ortiz-Vega, S., Rapley, J., Papageorgiou, A., & Dai, N. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90645.2008 · Cited by 400

Regulation of Autophagy by mTOR Signaling Pathway

Wang, Y., & Zhang, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-0602-4_3 · Cited by 363

The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein–protein interactions

Pennington, K. L., Ty, C., Torres, M. P., & Andersen, J. (2018) · Oncogene · doi:10.1038/s41388-018-0348-3 · Cited by 383

Nutrient Sensing, Metabolism, and Cell Growth Control

Yuan, H.-X., Xiong, Y., & Guan, K. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.019 · Cited by 376

Interference between concurrent resistance and endurance exercise: Molecular bases and the role of individual training variables

Fyfe, J. J., Bishop, D. J., & Stepto, N. K. (2014) · Sports Medicine · doi:10.1007/s40279-014-0162-1 · Cited by 347

Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease

Fraisl, P., Aragonés, J., & Carmeliet, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2761 · Cited by 326

The ATM protein kinase and cellular redox signaling: beyond the DNA damage response

Ditch, S., & Paull, T. T. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.10.002 · Cited by 333

Signaling Pathways Involved in the Regulation of mRNA Translation

Roux, P. P., & Topisirović, I. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00070-18 · Cited by 332

Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling

Drummond, M. J., Dreyer, H. C., Fry, C. S., Glynn, E. L., & Rasmussen, B. B. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91397.2008 · Cited by 322

Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling

Appenzeller‐Herzog, C., & Hall, M. N. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.02.006 · Cited by 324

Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends

Matter, M. S., Decaens, T., Andersen, J. B., & Thorgeirsson, S. S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.031 · Cited by 314

mTOR and the control of whole body metabolism

Polak, P., & Hall, M. N. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.024 · Cited by 310

Growing knowledge of the mTOR signaling network

Huang, K., & Fingar, D. C. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.09.011 · Cited by 310

Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications

Ostrovidov, S., Hosseini, V., Ahadian, S., Fujie, T., Parthiban, S. P., Ramalingam, M., Bae, H., Kaji, H., & Khademhosseini, A. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2013.0534 · Cited by 302

Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways

Masson, N., & Ratcliffe, P. J. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-3 · Cited by 305

mTOR Pathways in Cancer and Autophagy

Paquette, M., El–Houjeiri, L., & Pause, A. (2018) · Cancers · doi:10.3390/cancers10010018 · Cited by 301

Warburg Meets Autophagy: Cancer-Associated Fibroblasts Accelerate Tumor Growth and Metastasis via Oxidative Stress, Mitophagy, and Aerobic Glycolysis

Pavlides, S., Vera, I., Gândara, R., Sneddon, S., Pestell, R. G., Mercier, I., Martinez‐Outschoorn, U., Whitaker‐Menezes, D., Howell, A., Sotgia, F., et al. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4243 · Cited by 299

Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps

Levy, O. A., Malagelada, C., & Greene, L. A. (2009) · APOPTOSIS · doi:10.1007/s10495-008-0309-3 · Cited by 300

Transcriptional Co-repressor Function of the Hippo Pathway Transducers YAP and TAZ

Kim, M., Kim, T., Johnson, R. L., & Lim, D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.015 · Cited by 293

Ribosomal Protein S6 Phosphorylation

Meyuhas, O. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.07.006 · Cited by 296

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma

Sun, E. J., Wankell, M., Palamuthusingam, P., McFarlane, C., & Hebbard, L. (2021) · Biomedicines · doi:10.3390/biomedicines9111639 · Cited by 292

Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy

Qian, X., Li, X., Cai, Q., Zhang, C., Yu, Q., Jiang, Y., Lee, J.-H., Hawke, D. H., Wang, Y., Xia, Y., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.027 · Cited by 284

Down-Regulation of Akt/Mammalian Target of Rapamycin Signaling Pathway in Response to Myostatin Overexpression in Skeletal Muscle

Amirouche, A., Durieux, A., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., Bigard, X. A., Peinnequin, A., & Freyssenet, D. G. (2008) · Endocrinology · doi:10.1210/en.2008-0959 · Cited by 301

The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease

Goul, C., Peruzzo, R., & Zoncu, R. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00641-8 · Cited by 280

mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α

Cam, H., Easton, J. B., High, A., & Houghton, P. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.030 · Cited by 266

Roles of small RNAs in tumor formation

Leva, G. D., & Croce, C. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.04.001 · Cited by 263

Nutrient Regulation of the mTOR Complex 1 Signaling Pathway

Kim, S. G., Buel, G. R., & Blenis, J. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0138-2 · Cited by 268

Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms

Dunlop, E. A., & Tee, A. R. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.012 · Cited by 263

Drug resistance in pancreatic cancer: Impact of altered energy metabolism

Grasso, C., Jansen, G., & Giovannetti, E. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.026 · Cited by 260

Translational control of immune responses: from transcripts to translatomes

Piccirillo, C. A., Bjur, E., Topisirović, I., Sonenberg, N., & Larsson, O. S. (2014) · Nature Immunology · doi:10.1038/ni.2891 · Cited by 250

A comprehensive map of the mTOR signaling network

Caron, É., Ghosh, S., Matsuoka, Y., Ashton‐Beaucage, D., Therrien, M., Lemieux, S., Perreault, C., Roux, P. P., & Kitano, H. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.108 · Cited by 248

Amino Acid Signaling in TOR Activation

Kim, J., & Guan, K. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062209-094414 · Cited by 239

Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke–induced pulmonary injury and emphysema

Yoshida, T., Mett, I. L., Bhunia, A. K., Bowman, J. C., Perez, M. J., Zhang, L., Gandjeva, A., Zhen, L., Chukwueke, U. N., Mao, T., et al. (2010) · Nature Medicine · doi:10.1038/nm.2157 · Cited by 234

RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation

Malagelada, C., Jin, Z. H., & Greene, L. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3928-08.2008 · Cited by 228

mTOR: on target for novel therapeutic strategies in the nervous system

Maiese, K., Chong, Z. Z., Shang, Y., & Wang, S. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.11.001 · Cited by 226

The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma

Nargund, A. M., Pham, C. G., Dong, Y., Wang, P. I., Osmangeyoglu, H. U., Xie, Y., Aras, Ö., Han, S., Oyama, T., Takeda, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.074 · Cited by 227

Differential Roles of GSK-3β During Myocardial Ischemia and Ischemia/Reperfusion

Zhai, P., Sciarretta, S., Galeotti, J., Volpe, M., & Sadoshima, J. (2011) · Circulation Research · doi:10.1161/circresaha.111.249532 · Cited by 218

Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stressPreprint

Young, R. M., Ackerman, D., Quinn, Z. L., Mancuso, A., Gruber, M., Liu, L., Giannoukos, D. N., Bobrovnikova-Marjon, E. V., Diehl, J. A., Keith, B., et al. (2013) · Genes & Development · doi:10.1101/gad.198630.112 · Cited by 221

Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response

Sesen, J., Dahan, P., Scotland, S., Saland, E., Dang, V. T., Lemarié, A., Tyler, B., Brem, H., Toulas, C., Moyal, E. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123721 · Cited by 220

Everolimus

Houghton, P. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1314 · Cited by 209

ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies

Ishizawa, J., Kojima, K., Chachad, D., Ruvolo, P. P., Ruvolo, V. R., Jacamo, R. O., Borthakur, G. M., Mu, H. H., Zeng, Z., Tabe, Y., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aac4380 · Cited by 208

mTOR and Beclin1: Two key autophagy‐related molecules and their roles in myocardial ischemia/reperfusion injury

Shi, B., Ma, M., Zheng, Y., Pan, Y., & Lin, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28125 · Cited by 211

HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5

Elorza, A., Soro-Arnáiz, I., Meléndez‐Rodríguez, F., Rodríguez-Vaello, V., Marsboom, G., de Cárcer, G., Acosta‐Iborra, B., Albacete-Albacete, L., Ordóñez, Á., Serrano‐Oviedo, L., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.017 · Cited by 212

Hypoxic Reactive Oxygen Species Regulate the Integrated Stress Response and Cell Survival

Liu, L., Wise, D. R., Diehl, J. A., & Simon, M. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805056200 · Cited by 206

Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders

Maiese, K. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12804 · Cited by 202

miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1

Hwang‐Verslues, W. W., Chang, P.-H., Wei, P.-C., Yang, C.-Y., Huang, C.-K., Kuo, W.-H., Shew, J.-Y., Chang, K.-J., Lee, E.-H., & Lee, W.-H. (2011) · Oncogene · doi:10.1038/onc.2010.618 · Cited by 205

Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis

Horak, P., Crawford, A. R., Vadysirisack, D. D., Nash, Z. M., DeYoung, M. P., Sgroi, D. C., & Ellisen, L. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907705107 · Cited by 201

The role of autophagy in tumour development and cancer therapy

Rosenfeldt, M. T., & Ryan, K. M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001306 · Cited by 203

The emerging multiple roles of nuclear Akt

Martelli, A. M., Tabellini, G., Bressanin, D., Ognibene, A., Goto, K., Cocco, L., & Evangelisti, C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.017 · Cited by 205

A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity

Qiao, S., Dennis, M. J., Song, X., Vadysirisack, D. D., Salunke, D., Nash, Z. M., Yang, Z., Liesa, M., Yoshioka, J., Matsuzawa, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8014 · Cited by 199

Regulation of mRNA Translation by Signaling PathwaysPreprint

Roux, P. P., & Topisirovic, I. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012252 · Cited by 206

Small-molecule inhibitors of HIF-2a translation link its 5'UTR iron-responsive element to oxygen sensing

Zimmer, M., Ebert, B. L., Neil, C., Brenner, K., Papaioannou, I., Melas, A., Tolliday, N., Lamb, J., Pantopoulos, K., Golub, T., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.12.004 · Cited by 191

Interfering with Tumor Hypoxia for Radiotherapy Optimization

Telarović, I., Wenger, R. H., & Pruschy, M. N. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02000-x · Cited by 208

ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression

Whitney, M. L., Jefferson, L. S., & Kimball, S. R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.079 · Cited by 199

Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway

Nakajima (1992) · International Journal of Oncology · doi:10.3892/ijo_00000156 · Cited by 187

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)

Reinwald, M., Silva, J. T., Mueller, N. J., Fortün, J., Garzoni, C., de Fijter, J. W., Fernández‐Ruiz, M., Grossi, P., & Aguado, J. M. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.02.009 · Cited by 178

Autophagy and pattern recognition receptors in innate immunity

Delgado, M. A., Singh, S., Haro, S. A. D., Master, S. S., Ponpuak, M., Dinkins, C., Ornatowski, W., Vergne, I., & Deretic, V. P. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00725.x · Cited by 176

Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis

Musa, J., Orth, M. F., Dallmayer, M., Baldauf, M. C., Pardo, C., Rotblat, B., Kirchner, T., Leprivier, G., & Grünewald, T. G. P. (2016) · Oncogene · doi:10.1038/onc.2015.515 · Cited by 175

Molecular targeting of hypoxia in radiotherapy

Rey, S., Schito, L., Koritzinsky, M., & Wouters, B. G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.10.002 · Cited by 178

Hypoxia suppresses conversion from proliferative arrest to cellular senescence

Leontieva, O. V., Natarajan, V., Demidenko, Z. N., Burdelya, L. G., Gudkov, A. V., & Blagosklonny, M. V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205690109 · Cited by 169

Nucleolar Disruption in Dopaminergic Neurons Leads to Oxidative Damage and Parkinsonism through Repression of Mammalian Target of Rapamycin Signaling

Rieker, C., Engblom, D., Kreiner, G., Domanskyi, A., Schober, A., Stotz, S., Neumann, M., Yuan, X., Grummt, I., Schütz, G., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0590-10.2011 · Cited by 169

Hypoxia-Inducible Factors (HIFs) and Phosphorylation: Impact on Stability, Localization, and Transactivity

Kietzmann, T., Mennerich, D., & Dimova, E. Y. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00011 · Cited by 176

Lysosomal recruitment of TSC2 is a universal response to cellular stress

Demetriades, C., Plescher, M., & Teleman, A. A. (2016) · Nature Communications · doi:10.1038/ncomms10662 · Cited by 160

mTORC1 Signaling and Hypoxia

Brugarolas, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-271-1_4 · Cited by 4

REDD or dead?

McCarthy, N. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1517 · Cited by 1

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384

Cell-Type-Dependent Regulation of mTORC1 by REDD1 and the Tumor Suppressors TSC1/TSC2 and LKB1 in Response to Hypoxia

Wolff, N. C., Vega-Rubín-de-Celis, S., Xie, X., Castrillón, D. H., Kabbani, W., & Brugarolas, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01393-10 · Cited by 86

mTOR Activity Under Hypoxia

Vadysirisack, D. D., & Ellisen, L. W. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-430-8_4 · Cited by 49